Indication
MuSK
2 clinical trials
2 products
1 drug
Clinical trial
Long Term Safety Study of Amifampridine Phosphate in Patients With MuSK Antibody Positive and AChR (Acetylcholine Receptor) Antibody Positive Myasthenia GravisStatus: Terminated, Estimated PCD: 2022-08-05
Product
AmifampridineClinical trial
A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 3 Dose Levels of NMD670 Over 21 Days in Adult Patients With AChR/MuSK-Ab+ Myasthenia GravisStatus: Not yet recruiting, Estimated PCD: 2025-11-01
Product
NMD670Drug
Varlilumab